Relapse after complete response to anthracycline‐based combination chemotherapy in metastatic breast cancer
Pusztai L, Asmar L, Smith T, Hortobagyi G. Relapse after complete response to anthracycline‐based combination chemotherapy in metastatic breast cancer. Breast Cancer Research And Treatment 1999, 55: 1-8. PMID: 10472774, DOI: 10.1023/a:1006161906667.Peer-Reviewed Original ResearchConceptsAnthracycline-based combination chemotherapyComplete clinical responseDisease-free intervalMetastatic breast cancerInitial disease-free intervalSecond relapseFirst relapseCombination chemotherapyCR durationMedian survivalBreast cancerShorter CR durationSite of recurrenceLength of survivalMore frequent recurrenceClinical characteristicsClinical responseFirst recurrenceMetastatic diseaseVisceral sitesComplete responseClinical featuresMetastatic sitesSubsequent therapySecond recurrence